n.a. (TKMR)

4.02
0.08 1.95
NASDAQ
Prev Close 4.10
Open 4.22
Day Low/High 3.98 / 4.33
52 Wk Low/High 4.01 / 26.73
Volume 346.21K
Exchange NASDAQ
P/E Ratio N/A
Div & Yield N.A. (N.A)
Tekmira Announces Filing Of Definitive Proxy Statement And Voluntary Delisting From The TSX

Tekmira Announces Filing Of Definitive Proxy Statement And Voluntary Delisting From The TSX

Special Meeting of Shareholders to be Held March 3, 2015

Prepare for Volatility in the Morning

But I'm most uneasy with unimpressive action in individual stocks.  

Tekmira Initiates Phase I Clinical Trial Of TKM-HBV

Tekmira Initiates Phase I Clinical Trial Of TKM-HBV

TKM-HBV, a Leading RNAi Approach to Reduce Hepatitis B Surface Antigen, Has the Potential to Play a Central Role in the Cure of Chronic Hepatitis B Virus Infection

Tekmira Pharmaceuticals (TKMR) Weak On High Volume

Tekmira Pharmaceuticals (TKMR) Weak On High Volume

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a weak on high relative volume candidate

Perilous Reversal Watch: Tekmira Pharmaceuticals (TKMR)

Perilous Reversal Watch: Tekmira Pharmaceuticals (TKMR)

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a "perilous reversal" (up big yesterday but down big today) candidate

Tekmira Pharmaceuticals (TKMR) Stock Soars After OnCore Biopharma Acquisition Announcement

Tekmira Pharmaceuticals (TKMR) Stock Soars After OnCore Biopharma Acquisition Announcement

Shares of Tekmira Pharmaceuticals (TKMR) surged in morning trading Monday after the company agreed to acquire OnCore Biopharma to shift focus to developing hepatitis B virus treatments.

Heavy Trading On Tekmira Pharmaceuticals (TKMR) Before Market Open

Heavy Trading On Tekmira Pharmaceuticals (TKMR) Before Market Open

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a pre-market mover with heavy volume candidate

Tekmira Pharmaceuticals (TKMR) Stock Surges Today After Clinical Study Update

Tekmira Pharmaceuticals (TKMR) Stock Surges Today After Clinical Study Update

Shares of Tekmira Pharmaceuticals (TKMR) spiked Wednesday after the company provided an update on a Phase I/II clinical study.

Tekmira Pharmaceuticals (TKMR) Is Today's Strong On High Volume Stock

Tekmira Pharmaceuticals (TKMR) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a strong on high relative volume candidate

Tekmira Receives Clearance To Conduct A Phase I Clinical Study With TKM-HBV

Tekmira Receives Clearance To Conduct A Phase I Clinical Study With TKM-HBV

TKM-HBV is Designed to Treat Patients Chronically Infected With Hepatitis B Virus

Tekmira Pharmaceuticals (TKMR) Flagged As Strong On High Volume

Tekmira Pharmaceuticals (TKMR) Flagged As Strong On High Volume

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a strong on high relative volume candidate

'Mad Money' Lightning Round: I'll Take Popeye's Over Wendy's

'Mad Money' Lightning Round: I'll Take Popeye's Over Wendy's

Cramer can't recommend Dynavax Technologies but wants you to hold Noble Energy.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Cramer will be listening to conference calls next week but says a lot of the companies are better than their stocks.

Tekmira Pharmaceuticals (TKMR) Showing Signs Of Perilous Reversal Today

Tekmira Pharmaceuticals (TKMR) Showing Signs Of Perilous Reversal Today

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a "perilous reversal" (up big yesterday but down big today) candidate

Tekmira Announces Licensing And Collaboration Agreement With Dicerna

Tekmira Announces Licensing And Collaboration Agreement With Dicerna

Tekmira's LNP to Enable Dicerna's PH1 Candidate

One Factor Driving Tekmira Pharmaceuticals (TKMR) Stock Down Today

One Factor Driving Tekmira Pharmaceuticals (TKMR) Stock Down Today

Shares of Tekmira Pharmaceuticals (TKMR) are lower after the company's price target was lowered at Leerink Partners earlier on Monday.

Tekmira Provides Corporate Update And Announces Third Quarter 2014 Results

Tekmira Provides Corporate Update And Announces Third Quarter 2014 Results

Conference Call at 5:00 pm Eastern Time Today

TKMR December 26th Options Begin Trading

TKMR December 26th Options Begin Trading

Investors in Tekmira Pharmaceuticals Corp saw new options begin trading today, for the December 26th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TKMR options chain for the new December 26th contracts and identified one put and one call contract of particular interest.